Lukas Bajer
Overview
Explore the profile of Lukas Bajer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Brezina J, Bajer L, Wohl P, Duricova D, Hrabak P, Novotny A, et al.
J Clin Med
. 2021 Jul;
10(13).
PMID: 34206663
Background And Aims: Ulcerative colitis (UC) is a chronic inflammatory disease. Fecal microbial transplantation (FMT) is a promising alternative treatment. Methods: This multicenter, open-label, noninferiority trial randomized patients with active...
12.
Macinga P, Bajer L, Del Chiaro M, Chari S, Dite P, Frulloni L, et al.
Pancreatology
. 2021 Mar;
21(5):928-937.
PMID: 33775564
Background: Chronic pancreatitis is a known risk factor of pancreatic cancer (PDAC). A similar association has been suggested but not demonstrated for autoimmune pancreatitis (AIP). Objective: The aim of our...
13.
Krausova A, Buresova P, Sarnova L, Oyman-Eyrilmez G, Skarda J, Wohl P, et al.
Mucosal Immunol
. 2021 Mar;
14(3):691-702.
PMID: 33674761
Plectin, a highly versatile cytolinker protein, provides tissues with mechanical stability through the integration of intermediate filaments (IFs) with cell junctions. Here, we hypothesize that plectin-controlled cytoarchitecture is a critical...
14.
Schierova D, Brezina J, Mrazek J, Fliegerova K, Kvasnova S, Bajer L, et al.
Cells
. 2020 Oct;
9(10).
PMID: 33066233
Ulcerative colitis (UC) is an inflammatory bowel disease, and intestinal bacteria are implicated in the pathogenesis of this disorder. The administration of aminosalicylates (5-ASA) is a conventional treatment that targets...
15.
Coufal S, Galanova N, Bajer L, Gajdarova Z, Schierova D, Jiraskova Zakostelska Z, et al.
Cells
. 2019 Jul;
8(7).
PMID: 31337064
Crohn's disease (CD), ulcerative colitis (UC) and inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC-IBD), share three major pathogenetic mechanisms of inflammatory bowel disease (IBD)-gut dysbiosis, gut barrier...
16.
Bajer L, Pitra Z, Repicky J, Holena M
Evol Comput
. 2018 Dec;
27(4):665-697.
PMID: 30540493
This article deals with Gaussian process surrogate models for the Covariance Matrix Adaptation Evolutionary Strategy (CMA-ES)-several already existing and two by the authors recently proposed models are presented. The work...
17.
Bajer L, Slavcev A, Macinga P, Sticova E, Brezina J, Roder M, et al.
World J Gastroenterol
. 2018 Nov;
24(43):4939-4949.
PMID: 30487703
Aim: To evaluate risk factors for primary sclerosing cholangitis (PSC) recurrence (rPSC) after orthotopic liver transplantation (OLT) in patients with well-preserved colons. Methods: We retrospectively evaluated the medical records of...
18.
Drastich P, Bajer L, Kverka M
Vnitr Lek
. 2018 Sep;
64(6):665-671.
PMID: 30223665
Human gut microbiota, complex ecosystem of microbes associated with human gut, is essential for the development of the host's immune system and many other physiological functions. Recently, numerous diseases and...
19.
Bajer L, Wohl P, Drastich P
Vnitr Lek
. 2018 Sep;
64(6):659-664.
PMID: 30223664
Primary sclerosing cholangitis (PSC) is a progressive disease of the biliary tree which represents one of the most frequent indications for orthotopic liver transplantation (OLTx) in developed countries. LTx is...
20.
Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, et al.
World J Gastroenterol
. 2017 Jul;
23(25):4548-4558.
PMID: 28740343
Aim: To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). Methods: Stool samples were collected and relevant clinical data obtained from 106...